Advertisement
Screener

ONEMEDNET CORPORATION (ONMD) EBITDA

ONEMEDNET CORPORATION (ONMD) EBITDA

  • 2026-06-30: Basis Reported; EBITDA (m); Operating income -$2.26M; Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA -$2.54M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$3.07M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$2.23M*; Operating income -$2.23M; Depreciation and amortization $10.00K*.

Complete source-backed ebitda history.

Available history
2022-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported(m)-$2.26M(m)$292.00K(m)$9.00K*-$1.88M*(m)$324.00K(m)(m)
2026-03-31Reported-$2.54M(m)(m)(m)-2646.88%$2.00K-$1.54M(m)$311.00K(m)(m)
2025-12-31Reported-$3.07M(m)(m)(m)-344.89%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$2.23M*-$2.23M$10.00K*$177.00K-1257.06%*$0.00*-$1.75M*(m)$323.00K(m)(m)
2025-06-30Reported-$2.03M*-$2.06M$34.00K*$155.00K-1309.03%*$3.00K*-$2.19M*(m)$382.00K(m)(m)
2025-03-31Reported-$2.21M(m)(m)(m)-1614.60%$5.00K-$1.85M(m)$348.00K(m)(m)
2024-12-31Reported-$2.69M(m)(m)(m)-10346.15%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$2.33M*-$2.34M$10.00K*$142.00K-1638.03%*$9.00K*-$1.90M*(m)$298.00K(m)(m)
2024-06-30Reported-$2.44M*-$2.45M$10.00K*$227.00K-1076.65%*$1.00K*-$1.51M*(m)$383.00K(m)(m)
2024-03-31Reported-$2.09M(m)(m)(m)-842.74%$6.00K-$1.55M(m)$445.00K(m)(m)
2023-12-31Reported-$1.86M(m)(m)(m)-546.76%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$1.92M*-$1.93M$6.00K*$326.00K-589.26%*$21.00K*-$1.10M*(m)$405.00K(m)$87.71K
2023-06-30Reported-$1.56M*-$1.57M$7.00K*$173.00K-904.05%*(m)-$964.00K*(m)$579.00K(m)$62.71K
2023-03-31Reported-$1.46M(m)(m)(m)-731.50%(m)-$1.00M(m)$582.00K(m)$59.60K
2022-12-31Reported-$7.66M(m)(m)(m)-2905.01%(m)(m)(m)(m)(m)(m)
2022-09-30Reported(m)-$2.94M(m)$375.00K(m)(m)-$2.91M*(m)$597.00K(m)$106.72K
2022-06-30Reported(m)-$794.50K(m)(m)(m)(m)-$151.65K*(m)(m)(m)(m)
2022-03-31Reported(m)-$610.18K(m)(m)(m)(m)-$294.02K(m)(m)(m)(m)
2021-09-30Reported(m)-$98.72K(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30Reported(m)-$70.49K(m)(m)(m)(m)(m)(m)(m)(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$9.6M(m)(m)(m)-706.55%$13.00K-$7.50M(m)$1.51M(m)$1.00K
2024-12-31Reported-$9.55M(m)(m)(m)-1484.91%$51.00K-$6.95M(m)$1.47M(m)$2.00K
2023-12-31Reported-$6.83M(m)(m)(m)-668.46%$44.00K-$4.79M(m)$2.06M(m)$18.00K
2022-12-31Reported-$11.4M(m)(m)(m)-989.01%$58.00K-$4.70M(m)$1.59M(m)$17.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
NRC HEALTH (NRC)United States$0.450B42.50
OmniAb, Inc. (OABI)United States$0.698B-8.05
Absci Corp (ABSI)United States$1.775B-14.92
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14